Department of Molecular and Developmental Medicine, University of Siena, Italy.
GRID RIO Consulting, Rio de Janeiro, Brazil.
Eur J Public Health. 2018 Jun 1;28(3):439-444. doi: 10.1093/eurpub/ckx197.
In 2015-16, the European Union/European Economic Area Member States (EU/EEA MSs) experienced an unprecedented volume and rate of migration, posing serious challenges to existing national immunization systems and strategies and raising the questions of where, when and who to vaccinate. We assessed existing strategies for vaccinating immigrant populations in the EU/EEA using measles as an example of the most important vaccine-preventable diseases.
In this cross-sectional study, conducted from March to May 2016, an electronic questionnaire was sent to the Heads of National Immunization Technical Advisory Groups (NITAGs) or equivalent policy-making bodies in each of the 31 EU/EEA Member States. Responses were entered into a structured database and validated by survey responders for final analysis.
Validated responses from all 31 EU/EEA NITAGs or equivalents showed that there is no common measles immunization policy for European immigrants. Policies vary widely from no policy at all (9 of 31, 29%) to vaccination of all comers (2 of 31, 6%), or vaccination of selected cohorts based on vaccination history (17 of 31, 55%) or serum antibody analysis (2 of 31, 6%). Further, the operational responsibilities for immigrant vaccination and documentation methods are not unified within the EU/EEA region.
With some notable exceptions immunization policies to contain spread of infectious diseases through migration are either non-existent or vary widely between countries in the EU/EEA. With freedom of movement within the EU/EEA there ought to be harmonization and a common EU/EEA vaccination strategy to replace national policies for immigrant populations.
2015-16 年,欧盟/欧洲经济区成员国(EU/EEA MSs)经历了前所未有的移民规模和速度,这对现有的国家免疫计划和策略构成了严重挑战,并提出了在何处、何时以及为谁接种疫苗的问题。我们以麻疹为例,评估了欧盟/欧洲经济区为移民人群接种疫苗的现有策略,麻疹是最重要的疫苗可预防疾病之一。
在这项横断面研究中,我们于 2016 年 3 月至 5 月期间,向 31 个欧盟/欧洲经济区成员国的国家免疫技术咨询小组(NITAG)或同等政策制定机构的负责人发送了一份电子问卷。答复被输入到一个结构化数据库中,并由调查答复者进行验证,以进行最终分析。
来自所有 31 个欧盟/欧洲经济区 NITAG 或同等机构的有效答复表明,欧洲移民没有共同的麻疹免疫政策。政策差异很大,从根本没有政策(31 个中的 9 个,29%)到为所有新来者接种疫苗(31 个中的 2 个,6%),或者根据接种史(31 个中的 17 个,55%)或血清抗体分析(31 个中的 2 个,6%)选择特定人群接种疫苗。此外,欧盟/欧洲经济区区域内,移民接种疫苗和文件记录方法的运营责任尚未统一。
除了一些值得注意的例外情况,通过移民来控制传染病传播的免疫政策要么不存在,要么在欧盟/欧洲经济区各国之间存在很大差异。在欧盟/欧洲经济区内自由流动的情况下,应该协调一致,并制定欧盟/欧洲经济区的共同接种战略,以取代针对移民人口的国家政策。